INKT
MiNK Therapeutics (INKT)
$72
About MiNK Therapeutics (INKT)
MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.
Details
Daily high
$0.75
Daily low
$0.72
Price at open
$0.75
52 Week High
$1.90
52 Week Low
$0.71
Market cap
28.4M
Dividend yield
0.00%
Volume
14,435
Avg. volume
17,917
P/E ratio
-1.47
MiNK Therapeutics News
Details
Daily high
$0.75
Daily low
$0.72
Price at open
$0.75
52 Week High
$1.90
52 Week Low
$0.71
Market cap
28.4M
Dividend yield
0.00%
Volume
14,435
Avg. volume
17,917
P/E ratio
-1.47